SEC Form 4 · accession 0001645627-17-000144
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Nov 30, 2017
Accepted (ET)
Dec 5, 2017 · 1:36 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 30, 2017 | P | 3,000 | $0.062 | A | 24,308,189 | D | |
| Common Stock | Nov 30, 2017 | P | 3,000 | $0.0624 | A | 24,311,189 | D | |
| Common Stock | Nov 30, 2017 | P | 3,000 | $0.0625 | A | 24,314,189 | D | |
| Common Stock | Nov 30, 2017 | P | 3,000 | $0.0625 | A | 24,317,189 | D | |
| Common Stock | Nov 30, 2017 | P | 2,000 | $0.0618 | A | 24,319,189 | D | |
| Common Stock | Nov 30, 2017 | P | 2,000 | $0.0624 | A | 24,321,189 | D | |
| Common Stock | Dec 1, 2017 | P | 3,000 | $0.0623 | A | 24,324,189 | D | |
| Common Stock | Dec 1, 2017 | P | 3,000 | $0.063 | A | 24,327,189 | D | |
| Common Stock | Dec 1, 2017 | P | 3,000 | $0.06 | A | 24,330,189 | D | |
| Common Stock | Dec 1, 2017 | P | 3,000 | $0.06 | A | 24,333,189 | D | |
| Common Stock | Dec 1, 2017 | P | 3,000 | $0.06 | A | 24,336,189 | D | |
| Common Stock | Dec 4, 2017 | P | 3,000 | $0.0599 | A | 24,339,189 | D | |
| Common Stock | Dec 4, 2017 | P | 3,000 | $0.0611 | A | 24,342,189 | D | |
| Common Stock | Dec 4, 2017 | P | 3,000 | $0.0603 | A | 24,345,189 | D | |
| Common Stock | Dec 4, 2017 | P | 3,000 | $0.0609 | A | 24,348,189 | D | |
| Common Stock | Dec 4, 2017 | P | 3,000 | $0.0606 | A | 24,351,189 | D | |
| Common Stock | Dec 4, 2017 | P | 3,000 | $0.0589 | A | 24,354,189 | D | |
| Common Stock | Dec 4, 2017 | P | 3,000 | $0.0589 | A | 24,357,189 | D |
Table II — derivative securities
No Table II lines on this filing.